Price:
$21.99 $24.99
Stock:
Sold out

Description

Premium Coffee Roast Cups - Outbreak Coffee Doomsday Dark Roast

If you're looking for a new & improved coffee blend to pop in to your morning K-Cup, Outbreak has the ultimate product for you. Outbreak Coffee Doomsday Dark Roast combines Coffee with Ashwagandha!! Doomsday Dark Roast contains a whopping 200mg of KSM66 Ashwagandha in each serving. Doomsday Dark Roast will help to give you a major boost of energy, while also providing you with stress & Anxiety relief. The taste is extremely unique & delicious as well. Prepare to be carefree & focused after sippin' a morning cup! Pick up a box today! Introducing Outbreak Coffee Doomsday Dark Roast K-Cups!!

Outbreak Coffee Doomsday Dark Roast Benefits

  • Each Cup Contains 200mg of KSM66 Ashwagandha
  • Helps To Promote Mental Clarity
  • Supports Healthy Responses To Stress & Stressful Situations
  • Delicious & Unique Coffee Taste
  • Provides Sex Drive Assistance In Men
  • Helps To Lower Anxiety Levels
  • Promotes Utmost Concentration 

How Do I Take Outbreak Coffee Doomsday Dark Roast?

Outbreak recommends enjoying one (1) K-Cup whenever you need a little energy boost. Just insert the K-Cup into your Keurig machine, brew, & enjoy!

Outbreak Coffee Doomsday Dark Roast Ingredients

Serving Size: 1 K Cup

Servings Per Container: 24

100% Arabica Coffee

KSM Ashwagandha Extract 200mg

Other Ingredients: None.

Outbreak Coffee Doomsday Dark Roast Side Effects & Warnings

Store in a cool, dry place. Keep out of reach of children.

References

Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes [published correction appears in BMJ. 2018 Jan 12;360:k194]. BMJ. 2017;359:j5024. Published 2017 Nov 22. doi:10.1136/bmj.j5024

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696634/

 

Kurapati KR, Atluri VS, Samikkannu T, Nair MP. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One. 2013;8(10):e77624. Published 2013 Oct 16. doi:10.1371/journal.pone.0077624

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797707/